FindTrial
Sign In

A prospective study of the diagnosis and treatment for children with autoimmune encephalitis.

A prospective study of the diagnosis and treatment for children with autoimmune encephalitis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016662
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune encephalitis

Interventions

Case series:First line: Intravenous immunoglobulin and ocorticoid treatment
second line: depends on the Rankins score and by Rituximab or cyclic lindamides, or Mycophenolate or azathioprine

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) There are autoimmune encephalitis related neurologic and psychiatric symptoms, 2) autoimmune encephalitis antibody test was positive in blood and cerebrospinal fluid (anti NMDAR, AMPA1, AMPA2, LGI1, CASPR2, GABA antibody), and diagnosis of autoimmune encephalitis.

Exclusion criteria

Exclusion criteria: Patients who can not cooperate with treatment or follow-up.

Design outcomes

Primary

MeasureTime frame
mRS;—

Countries

China

Contacts

Public ContactZhong Min

Children's Hospital of Chongqing Medical University

cy_zm11@126.com+86 13657691847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026